MétaCan
Menu
Back to cohort
Record W2900305229 · doi:10.1093/neuonc/noy148.316

DRES-09. IN VIVO FUNCTIONAL GENOMICS IDENTIFIES DRIVERS OF CHEMORESISTANCE IN MEDULLOBLASTOMA

2018· article· en· W2900305229 on OpenAlexaff
Ana Guerreiro Stücklin, Livia Garzia, Patryk Skowron, Pasqualino De Antonellis, Carolina Nör, Xiaochong Wu, Michael D. Taylor

Bibliographic record

VenueNeuro-Oncology · 2018
Typearticle
Languageen
FieldMedicine
TopicMultiple Myeloma Research and Treatments
Canadian institutionsMcGill UniversityHospital for Sick Children
Fundersnot available
KeywordsMedulloblastomaChemotherapyBiologyCancer researchSonic hedgehogMetastasisOncologyCancerMedicineInternal medicineGeneGenetics

Abstract

fetched live from OpenAlex

Brain tumours are the main cause of cancer-related death during childhood and medulloblastoma an aggressive embryonal tumour that arises in the posterior fossa – is the most common malignant tumour in this age group. Chemotherapy is a cornerstone of the postsurgical treatment, particularly in younger children in whom craniospinal irradiation is omitted due to the devastating side effects in the developing brain. Medulloblastoma often progresses or recurs after chemotherapy with a dismal prognosis. We used the Sleeping Beauty (SB) transposon-driven Ptch+/−/Math1-SB11/T2Onc sonic hedgehog (SHH) medulloblastoma murine model as a functional genomic tool to perform a genome-wide screen and identify genes and pathways that promote resistance to chemotherapy. After sub-total resection of the primary tumours, the mice were treated with repeated cycles of chemotherapy (cisplatin 5 mg/kg IP once on day 1 followed by cyclophosphamide 150 mg/kg IP daily from day 2 – 5) every 2 weeks for up to 3 cycles and monitored for tumour recurrence. The primary tumours (pre-treatment) and the tumours and metastasis that regrew after chemotherapy were deep sequenced to determine the transposon insertion sites. We identified recurrence-specific clonally selected insertions that promoted tumour growth despite therapy, including p53 (recurrently mutated in human tumours at relapse) and several other genes involved in DNA repair. Using cerebellar orthotopic models of p53-mutated SHH medulloblastoma, we observed a significant improvement in survival when the ATM inhibitor AZ32 was added to the chemotherapy backbone. This provides a rationale for developing therapeutic approaches targeting DNA repair in combination with conventional chemotherapy to prevent chemoresistance and medulloblastoma recurrence.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.004
Threshold uncertainty score0.014

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0040.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.028
GPT teacher head0.312
Teacher spread0.285 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2018
Admission routes1
Has abstractyes

Explore more

Same venueNeuro-OncologySame topicMultiple Myeloma Research and TreatmentsFrench-language works237,207